Oral Lichen Planus
115
11
16
64
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Research Maturity
64 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.5%
4 terminated out of 115 trials
94.1%
+7.6% vs benchmark
19%
22 trials in Phase 3/4
13%
8 of 64 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 64 completed trials
Clinical Trials (115)
Impact of Topical Clobetasol on Gingival Crevicular Fluid miRNAs in Subjects Affected by Oral Lichen Planus
Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model
Impact of PDT and Topical Corticosteroids on Taste Perception and Salivary Oxidative Stress Markers in Patients With OLP
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions
Periodontal Status in Patients With Oral Lichen Planus
Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience
Photobiomodulation, Photodynamic Therapy, and Clobetasol in the Treatment of Oral Lichen Planus.
Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP
Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus
Unveiling the Protein Expression Patterns in Oral Lichen Planus and Leukoplakia Through Comparative Salivary Proteomics
Discomfort Following Oral Biopsy Comparing Laser and Punch Biopsy
Role of Subgingival Instrumentation in Oral Lichen Planus
Effectiveness of a Sodium Hyaluronate 0.01% and Sh-Oligopeptide-85 SP Mouthwash for the Treatment of Symptomatic Oral Lichen Planus
Cardiovascular and Prothrombotic Risk in Patients With Oral Lichen Planus.
Evaluation of Artificial Intelligence in Diagnosis and Risk Assessment of Oral Potentially Malignant Disorders
Efficacy and Safety of add-on Apremilast Versus add-on Methotrexate in Patients With Oral Lichen Planus
Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus